Cargando…

The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients

BACKGROUND: Smoking rates in methadone-maintained patients are almost three times higher than in the general population and remain elevated and stable. Due to the various negative health effects of smoking, nicotine dependence contributes to the high mortality in this patient group. The purpose of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wapf, Victoria, Schaub, Michael, Klaeusler, Beat, Boesch, Lukas, Stohler, Rudolf, Eich, Dominique
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2276187/
https://www.ncbi.nlm.nih.gov/pubmed/18348722
http://dx.doi.org/10.1186/1477-7517-5-10
_version_ 1782151973862113280
author Wapf, Victoria
Schaub, Michael
Klaeusler, Beat
Boesch, Lukas
Stohler, Rudolf
Eich, Dominique
author_facet Wapf, Victoria
Schaub, Michael
Klaeusler, Beat
Boesch, Lukas
Stohler, Rudolf
Eich, Dominique
author_sort Wapf, Victoria
collection PubMed
description BACKGROUND: Smoking rates in methadone-maintained patients are almost three times higher than in the general population and remain elevated and stable. Due to the various negative health effects of smoking, nicotine dependence contributes to the high mortality in this patient group. The purpose of the current study was to investigate Swiss methadone and buprenorphine-maintained patients' willingness to stop smoking and to clarify further smoking cessation procedures. METHODS: Substance abuse history, nicotine dependence, and readiness to stop smoking were assessed in a sample of 103 opiate-dependent patients in the metropolitan area of Zurich, Switzerland. Patients were asked to document their smoking patterns and readiness to quit. RESULTS: Only a small number of patients were willing to quit smoking cigarettes (10.7%) and, even though bupropione or nicotine replacement therapy was included in the fixed daily treatment care, only one patient received nicotine replacement therapy for smoking cessation. A diagnosis of depression in patients' clinical records was associated with readiness to stop smoking. No significant associations were found between readiness to quit smoking and age, methadone treatment characteristics, and presence of co-dependencies. CONCLUSION: The current prescription level of best medicine for nicotine dependence in Swiss methadone and buprenorphine-maintained patients is far from adequate. Possible explanations and treatment-relevant implications are discussed.
format Text
id pubmed-2276187
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-22761872008-03-28 The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients Wapf, Victoria Schaub, Michael Klaeusler, Beat Boesch, Lukas Stohler, Rudolf Eich, Dominique Harm Reduct J Research BACKGROUND: Smoking rates in methadone-maintained patients are almost three times higher than in the general population and remain elevated and stable. Due to the various negative health effects of smoking, nicotine dependence contributes to the high mortality in this patient group. The purpose of the current study was to investigate Swiss methadone and buprenorphine-maintained patients' willingness to stop smoking and to clarify further smoking cessation procedures. METHODS: Substance abuse history, nicotine dependence, and readiness to stop smoking were assessed in a sample of 103 opiate-dependent patients in the metropolitan area of Zurich, Switzerland. Patients were asked to document their smoking patterns and readiness to quit. RESULTS: Only a small number of patients were willing to quit smoking cigarettes (10.7%) and, even though bupropione or nicotine replacement therapy was included in the fixed daily treatment care, only one patient received nicotine replacement therapy for smoking cessation. A diagnosis of depression in patients' clinical records was associated with readiness to stop smoking. No significant associations were found between readiness to quit smoking and age, methadone treatment characteristics, and presence of co-dependencies. CONCLUSION: The current prescription level of best medicine for nicotine dependence in Swiss methadone and buprenorphine-maintained patients is far from adequate. Possible explanations and treatment-relevant implications are discussed. BioMed Central 2008-03-18 /pmc/articles/PMC2276187/ /pubmed/18348722 http://dx.doi.org/10.1186/1477-7517-5-10 Text en Copyright © 2008 Wapf et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Wapf, Victoria
Schaub, Michael
Klaeusler, Beat
Boesch, Lukas
Stohler, Rudolf
Eich, Dominique
The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients
title The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients
title_full The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients
title_fullStr The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients
title_full_unstemmed The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients
title_short The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients
title_sort barriers to smoking cessation in swiss methadone and buprenorphine-maintained patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2276187/
https://www.ncbi.nlm.nih.gov/pubmed/18348722
http://dx.doi.org/10.1186/1477-7517-5-10
work_keys_str_mv AT wapfvictoria thebarrierstosmokingcessationinswissmethadoneandbuprenorphinemaintainedpatients
AT schaubmichael thebarrierstosmokingcessationinswissmethadoneandbuprenorphinemaintainedpatients
AT klaeuslerbeat thebarrierstosmokingcessationinswissmethadoneandbuprenorphinemaintainedpatients
AT boeschlukas thebarrierstosmokingcessationinswissmethadoneandbuprenorphinemaintainedpatients
AT stohlerrudolf thebarrierstosmokingcessationinswissmethadoneandbuprenorphinemaintainedpatients
AT eichdominique thebarrierstosmokingcessationinswissmethadoneandbuprenorphinemaintainedpatients
AT wapfvictoria barrierstosmokingcessationinswissmethadoneandbuprenorphinemaintainedpatients
AT schaubmichael barrierstosmokingcessationinswissmethadoneandbuprenorphinemaintainedpatients
AT klaeuslerbeat barrierstosmokingcessationinswissmethadoneandbuprenorphinemaintainedpatients
AT boeschlukas barrierstosmokingcessationinswissmethadoneandbuprenorphinemaintainedpatients
AT stohlerrudolf barrierstosmokingcessationinswissmethadoneandbuprenorphinemaintainedpatients
AT eichdominique barrierstosmokingcessationinswissmethadoneandbuprenorphinemaintainedpatients